comparemela.com

Page 8 - Biopharma Holdings News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research Analysts Issue Forecasts for Xeris Biopharma Holdings, Inc s Q1 2024 Earnings (NASDAQ:XERS)

Research Analysts Issue Forecasts for Xeris Biopharma Holdings, Inc s Q1 2024 Earnings (NASDAQ:XERS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Xeris Biopharma (XERS) Scheduled to Post Earnings on Wednesday

Xeris Biopharma (NASDAQ:XERS – Get Free Report) will post its quarterly earnings results before the market opens on Wednesday, March 6th. Analysts expect Xeris Biopharma to post earnings of ($0.09) per share for the quarter. Xeris Biopharma Price Performance NASDAQ:XERS traded up $0.14 during midday trading on Thursday, hitting $3.16. 471,355 shares of the stock […]

Matinas BioPharma Holdings, Inc (NYSEAMERICAN:MTNB) Shares Sold by Staley Capital Advisers Inc

Matinas BioPharma Holdings, Inc (NYSEAMERICAN:MTNB) Shares Sold by Staley Capital Advisers Inc
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

ADRs End Flat; Tuniu Climbs 16%

ADRs End Flat; Tuniu Climbs 16%
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

ADRs End Flat; Tuniu Climbs 16%

This article was automatically generated by MarketWatch using technology from Automated Insights. International stocks trading in New York closed flat on Friday, as the S&P/BNY Mellon index of. -February 23, 2024 at 04:53 pm EST - MarketScreener

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.